Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.42 |
| ▸ | PEPD | P12955 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | MB | P02144 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | RARG | P13631 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1713162 | 0.86 | CA1 (0.51) | CA1CA2ALDH1A1MEN1MAPT | |
| Hydrochloric Acid SCHEMBL1143828 | 0.84 | CA1 (0.50) | CA1CA2ALDH1A1MEN1MAPT | |
| SCHEMBL11884077 | 0.84 | CA1 (0.42) | CA1CA2ALDH1A1MEN1MAPT | |
| SCHEMBL1372423 | 0.81 | POLB (0.63) | CA1CA2ALDH1A1MEN1MAPT | |
| SCHEMBL20594029 | 0.81 | ALDH1A1 (0.47) | ALDH1A1MEN1MAPTKMT2ATSHR | |
| SCHEMBL16554941 | 0.80 | POLB (0.43) | CA1CA2ALDH1A1MEN1MAPT | |
| SCHEMBL1376178 | 0.80 | CA1 (0.49) | CA1CA2ALDH1A1MEN1MAPT | |
| Hydrochloric Acid SCHEMBL3661595 | 0.80 | POLB (0.61) | CA1CA2ALDH1A1MEN1MAPT | |
| SCHEMBL9745182 | 0.78 | CYP1A1 (0.52) | CA1CA2ALDH1A1MEN1MAPT | |
| SCHEMBL22354 | 0.78 | CYP1A1 (0.52) | CA1CA2ALDH1A1MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622577-B2 | Processes for the preparation of cephalosporin derivatives | CJ CHEILJEDANG CORPORATION (KR) | 2009-11-24 | — | — | US | disclosed |
| US-20090221815-A1 | PROCESSES FOR THE PREPARATION OF CEPHEM DERIVATIVES | CJ CHEILJEDANG CORPORATION (KR) | 2009-09-03 | — | — | US | disclosed |
| US-7544797-B2 | Processes for the preparation of cephem derivatives | CJ CHEILJEDANG CORPORATION (KR) | 2009-06-09 | — | — | US | disclosed |
| EP-1678187-A4 | PROCESSES FOR THE PREPARATION OF CEPHALOSPORIN DERIVATIVES | CJ CORP (KR) | 2007-06-13 | — | — | EP | disclosed |
| EP-1678186-A4 | PROCESSES FOR THE PREPARATION OF CEPHEM DERIVATIVES | CJ CORP (KR) | 2007-04-25 | — | — | EP | disclosed |
| US-20070083042-A1 | Processes for the preparation of cephalosporin derivatives | CJ CORPORATION (KR) | 2007-04-12 | — | — | US | disclosed |
| US-20070060747-A1 | Processes for the preparation of cephem derivatives | CJ CORPORATION (KR) | 2007-03-15 | — | — | US | disclosed |
| EP-1678187-A1 | PROCESSES FOR THE PREPARATION OF CEPHALOSPORIN DERIVATIVES | CJ Corporation (KR) | 2006-07-12 | — | — | EP | disclosed |
| EP-1678186-A1 | PROCESSES FOR THE PREPARATION OF CEPHEM DERIVATIVES | CJ Corporation (KR) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005042544-A1 | PROCESSES FOR THE PREPARATION OF CEPHALOSPORIN DERIVATIVES | CJ CORPORATION (KR) | 2005-05-12 | — | — | WO | disclosed |
| WO-2005042543-A1 | PROCESSES FOR THE PREPARATION OF CEPHEM DERIVATIVES | CJ CORPORATION (KR) | 2005-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060747-A1 | Processes for the preparation of cephem derivatives | CEP170, HAMP, NISCH | CA1 2056/4885CA2 324/4885ALDH1A1 1991/4885 |
| US-20070083042-A1 | Processes for the preparation of cephalosporin derivatives | ADH1C, HSD17B14, ADH1A | CA1 2219/4885CA2 2577/4885ALDH1A1 39/4885 |
| US-20090221815-A1 | PROCESSES FOR THE PREPARATION OF CEPHEM DERIVATIVES | CEP170, HAMP, NISCH | CA1 2056/4885CA2 324/4885ALDH1A1 1991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.